P3.13C.09 First-Line Treatments for Advanced Pure Large Cell Neuroendocrine Tumors (LCNEC):Insights from a Global Clinico-Genomic Study

• Published in: Journal of thoracic oncology Vol. 19; no. 10; pp. S358 - S359
• Main Authors: Nassar, A.H., Matteson, K., Adeyelu, T., Ocejo, A., Ardeshir, F., Leal, T., Ramalingam, S., Gray, J.E., Hicks, K., Kaldas, D., Baena, J., Zurera Berjaga, M., Kwiatkowski, D.J., Aboubakar Nana, F., Grohe, C., Leuders, H., Citarella, F., Cortellini, A., Mingo, E.C., Pancirer, D., Das, M., John Ellis-Caleo, T., Cheung, J.M., Lin, J.J., Watson, A., Camidge, R., Sridhar, A., Parikh, K., Crowley, F., Marron, T., Aggarwal, V., Murtaza, A., Sankar, K., Kawtharany, H., Zhang, J., Owen, D., Li, M., Nagasaka, M., Pinato, D., Alhamad, K., Puri, S., Awosika, N., Zaman, U., Evans, M., Vanderwalde, A., Lopez, G., borghaei, h., Kim, C., Naqash, A.R., Chiang, A.
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.10.2024
• ISSN: 1556-0864
• DOI: 10.1016/j.jtho.2024.09.645